Sign in

CIK 0001053369 · Non-accelerated filer<br>Smaller reporting company

ELITE PHARMACEUTICALS INC /NV/

Sign in to watch
Ticker
ELTP
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Mar 31
Incorporated
NJ
Entity type
operating
EIN
223542636
Phone
2017502646
Business address
165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
Former names
ELITE PHARMACEUTICALS INC /DE/
Open-market buys, last 90 days
$34,590
in 2 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$34,590. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dash Barry H +$35K Director 2 filings

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2013-04-26 NIGALAYE ASHOK G Chief Scientific Officer Conversion +8,230,453 30,496,549
2013-04-26 NIGALAYE ASHOK G Chief Scientific Officer Conversion · Series E Convertible Preferred Stock −200 $1,000.00 $200K 1,600
2013-04-26 NIGALAYE ASHOK G Chief Scientific Officer Other disposition · Warrants −13,272,999 26,727,001
2013-04-26 EPIC PHARMA LLC 10% owner Returned to the company −243,926 $0.08 $20K 14,666,740
2013-04-26 EPIC PHARMA LLC 10% owner Conversion +8,230,453 22,897,193
2013-04-26 EPIC PHARMA LLC 10% owner Conversion · Series E Convertible Preferred Stock −200 $1,000.00 $200K 1,600
2013-04-26 EPIC PHARMA LLC 10% owner Other disposition · Warrants −13,272,999 26,727,001
2013-04-26 EPIC INVESTMENTS, LLC 10% owner Returned to the company −243,926 $0.08 $20K 14,666,740
2013-04-26 EPIC INVESTMENTS, LLC 10% owner Conversion +8,230,453 22,897,193
2013-04-26 EPIC INVESTMENTS, LLC 10% owner Conversion · Series E Convertible Preferred Stock −200 $1,000.00 $200K 1,600
2013-04-26 EPIC INVESTMENTS, LLC 10% owner Other disposition · Warrants −13,272,999 26,727,001
2013-04-25 POTTI RAM 10% owner Returned to the company −150,000 $0.08 $12K 16,682,019
2013-04-25 NARINE JEENARINE Director Returned to the company −150,000 $0.08 $12K 16,412,461
2013-04-25 NIGALAYE ASHOK G Chief Scientific Officer Returned to the company −150,000 $0.08 $12K 22,510,022
2013-04-25 EPIC PHARMA LLC 10% owner Returned to the company −150,000 $0.08 $12K 14,910,666
2013-04-25 EPIC INVESTMENTS, LLC 10% owner Returned to the company −150,000 $0.08 $12K 14,910,666
2013-03-25 NIGALAYE ASHOK G Chief Scientific Officer Other acquisition +6,775,068 $0.04 $250K 15,060,666
2013-03-25 NIGALAYE ASHOK G Chief Scientific Officer Other acquisition · Warrants +6,666,667 2,436,665
2013-03-25 NARINE JEENARINE Director Other acquisition +666,667 $0.04 $25K 15,060,666
2013-03-25 NARINE JEENARINE Director Other acquisition · Warrants +333,333 2,436,665

Page 16 of 18 · 356 trades